Inspire Medical Systems Free Cash Flow (FCF) History (INSP)

Inspire Medical Systems reported $78.5M in free cash flow for fiscal 2025, a decrease of 13.88% from the previous fiscal year, with a free cash flow margin of 8.61%.

View full Inspire Medical Systems company overview

Inspire Medical Systems free cash flow by year

Inspire Medical Systems annual free cash flow

Fiscal yearPeriod endedFree cash flowChangeGrowthFCF margin
20252025-12-31$78.5M−$12.6M−13.88%+8.61%
20242024-12-31$91.1M$90.1M+8798.73%+11.35%
20232023-12-31$1.0M−$1.4M−58.59%+0.16%
20222022-12-31$2.5M$27.3M+0.61%
20212021-12-31−$24.8M$30.7M−10.62%
20202020-12-31−$55.5M−$19.9M−48.10%
20192019-12-31−$35.6M−$16.6M−43.37%
20182019-01-01−$18.9M−$2.7M−37.44%
20172017-12-31−$16.2M−56.72%

Inspire Medical Systems free cash flow growth trends

Over the last five reported fiscal years, free cash flow grew from −$55.5M to $78.5M, a net increase of $134.0M. Inspire Medical Systems's latest reported quarter, Q2 2026, generated $14.1M in free cash flow, an increase of $20.4M year over year.

About the metric

What free cash flow means

Free cash flow is the cash a company generates from operations after capital expenditures. Positive FCF can fund dividends, buybacks, debt repayment, or reinvestment; negative FCF means capital spending exceeded operating cash flow for that period.

Calculation and source

How free cash flow is calculated

TickerStat calculates free cash flow as SEC-reported operating cash flow minus capital expenditures. FCF margin equals free cash flow divided by revenue. Fiscal periods can differ from calendar years, so the tables include exact period-end dates.

Review Inspire Medical Systems filings at SEC.gov ↗